연구성과로 돌아가기
JCR 2022 저널 목록 (1037 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Legal Studies | CAMBRIDGE UNIV PRESS | 0261-3875 | 1748-121X | SSCI | LAW | 450 | 0.7 | Q4 | 75.6 | 24.4 | 117/154 | 0.9 | Q3 | 0.7 | 0.4 | 1.13 | 98/425 | Q1 | 77.06 | 0.001 | 0.148 | 0.418 | Q3 | 41 | 100.0% | 7.9 | 11.8 | 41 | 41.8% | 2025-04-21 10:07:42 | 바로가기 |
| LIBRARY JOURNAL | REED BUSINESS INFORMATION | 0363-0277 | N/A | SSCI | INFORMATION SCIENCE & LIBRARY SCIENCE | 423 | 1.1 | Q4 | 75.6 | 24.4 | 64/84 | 0.8 | Q4 | 1.1 | 0.4 | 0.04 | 150/163 | Q4 | 8.28 | 0.000 | 0.086 | 0.263 | Q4 | 17 | 100.0% | 12.5 | 0.5 | 17 | 0.0% | 2025-04-21 10:05:25 | 바로가기 |
| MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | ELSEVIER | 0027-5107 | 1873-135X | SCIE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 5,937 | 2.3 | Q4 | 75.6 | 24.4 | 120/158 | 2.1 | Q4 | 2.3 | 0.7 | 0.48 | 122/169 | Q3 | 28.11 | 0.001 | 0.169 | 0.584 | Q2 | 26 | 96.2% | 16.8 | 8.0 | 25 | 13.2% | 2025-04-21 09:34:38 | 바로가기 |
| NEUROIMMUNOMODULATION | KARGER | 1021-7401 | 1423-0216 | SCIE | NEUROSCIENCES | 1,902 | 2.4 | Q4 | 75.6 | 24.4 | 206/272 | 2.7 | Q4 | 2.3 | 0.8 | 0.46 | 252/306 | Q4 | 17.81 | 0.001 | 0.181 | 0.517 | Q4 | 29 | 86.2% | 10.3 | 6.6 | 25 | 6.2% | 2025-04-21 10:19:13 | 바로가기 |
| NEUROLOGIC CLINICS | W B SAUNDERS CO-ELSEVIER INC | 0733-8619 | 1557-9875 | SCIE | NEUROSCIENCES | 3,384 | 2.4 | Q4 | 75.6 | 24.4 | 206/272 | 3.8 | Q2 | 2.3 | 0.1 | 0.77 | 157/306 | Q3 | 48.86 | 0.002 | 0.531 | 0.981 | Q2 | 54 | 100.0% | 8.1 | 7.6 | 54 | 3.2% | 2025-04-21 10:19:07 | 바로가기 |
| NEUROPSYCHOLOGY | AMER PSYCHOLOGICAL ASSOC | 0894-4105 | 1931-1559 | SCIE | NEUROSCIENCES | 6,224 | 2.4 | Q4 | 75.6 | 24.4 | 206/272 | 3.1 | Q3 | 2.3 | 0.5 | 0.83 | 138/306 | Q2 | 55.07 | 0.004 | 0.804 | 0.971 | Q3 | 88 | 92.0% | 11.7 | 10.6 | 81 | 0.4% | 2025-04-21 10:19:00 | 바로가기 |
| Pacific Focus | WILEY | 1225-4657 | 1976-5118 | SSCI | AREA STUDIES | 166 | 0.6 | Q4 | 75.6 | 24.4 | 64/84 | 0.7 | Q4 | 0.6 | 0.1 | 0.54 | 105/173 | Q3 | 39.60 | 0.000 | 0.042 | 0.222 | Q4 | 17 | 100.0% | 7.0 | 8.5 | 17 | 3.4% | 2025-04-21 09:31:58 | 바로가기 |
| PHARMAZIE | AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH | 0031-7144 | 0031-7144 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 3,892 | 1.6 | Q4 | 75.6 | 24.4 | 135/178 | 1.6 | Q3 | 1.6 | 0.2 | 0.33 | 138/230 | Q3 | 40.22 | 0.001 | 0.286 | 0.233 | Q3 | 56 | 100.0% | 11.6 | 8.7 | 56 | 0.0% | 2025-04-21 09:38:22 | 바로가기 |
| PHOTONIC NETWORK COMMUNICATIONS | SPRINGER | 1387-974X | 1572-8188 | SCIE | TELECOMMUNICATIONS | 820 | 1.7 | Q4 | 75.6 | 24.4 | 67/88 | 1.9 | Q3 | 1.6 | 0.3 | 0.48 | 78/116 | Q3 | 33.19 | 0.001 | 0.165 | 0.272 | Q4 | 33 | 100.0% | 4.5 | 6.5 | 33 | 1.6% | 2025-04-21 10:39:05 | 바로가기 |
| SOCIAL SCIENCE INFORMATION SUR LES SCIENCES SOCIALES | SAGE PUBLICATIONS LTD | 0539-0184 | 1461-7412 | SSCI | INFORMATION SCIENCE & LIBRARY SCIENCE | 1,959 | 1.1 | Q4 | 75.6 | 24.4 | 64/84 | 1.3 | Q3 | 1.1 | 0.4 | 0.46 | 70/163 | Q2 | 57.36 | 0.001 | 0.168 | 0.554 | Q3 | 16 | 100.0% | 19.8 | 13.9 | 16 | 37.4% | 2025-04-21 10:05:21 | 바로가기 |
| THERAPEUTIC APHERESIS AND DIALYSIS | WILEY | 1744-9979 | 1744-9987 | SCIE | UROLOGY & NEPHROLOGY | 1,985 | 1.9 | Q4 | 75.6 | 24.4 | 67/88 | 1.7 | Q4 | 1.7 | 0.2 | 0.45 | 79/125 | Q3 | 37.20 | 0.002 | 0.364 | 0.410 | Q4 | 134 | 90.3% | 7.6 | 7.5 | 121 | 9.6% | 2025-04-21 10:40:27 | 바로가기 |
| ACTA ANAESTHESIOLOGICA SCANDINAVICA | WILEY | 0001-5172 | 1399-6576 | SCIE | ANESTHESIOLOGY | 7,100 | 2.1 | Q4 | 75.7 | 24.3 | 27/35 | 2.1 | Q4 | 1.9 | 0.5 | 0.78 | 23/65 | Q2 | 65.38 | 0.006 | 1.287 | 0.782 | Q3 | 129 | 84.5% | 11.4 | 6.6 | 109 | 29.1% | 2025-04-21 09:30:47 | 바로가기 |
| ALZHEIMER DISEASE & ASSOCIATED DISORDERS | LIPPINCOTT WILLIAMS & WILKINS | 0893-0341 | 0893-0341 | SCIE | CLINICAL NEUROLOGY | 4,119 | 2.1 | Q4 | 75.7 | 24.3 | 161/212 | 3.0 | Q3 | 2.0 | 0.3 | 0.68 | 143/269 | Q3 | 47.03 | 0.003 | 0.553 | 0.987 | Q2 | 63 | 92.1% | 12.0 | 8.7 | 58 | 8.1% | 2025-04-21 09:39:45 | 바로가기 |
| APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | LIPPINCOTT WILLIAMS & WILKINS | 1541-2016 | 1533-4058 | SCIE | PATHOLOGY | 2,382 | 1.6 | Q4 | 75.7 | 24.3 | 58/76 | 1.7 | Q3 | 1.6 | 0.5 | 0.79 | 37/87 | Q2 | 58.05 | 0.002 | 0.524 | 0.438 | Q3 | 104 | 99.0% | 6.3 | 7.6 | 103 | 8.9% | 2025-04-21 10:23:08 | 바로가기 |
| BMC Molecular and Cell Biology | BMC | N/A | 2661-8850 | SCIE | CELL BIOLOGY | 620 | 2.8 | Q4 | 75.7 | 24.3 | 145/191 | 2.9 | Q4 | 2.8 | 0.6 | 0.38 | 168/203 | Q4 | 17.49 | 0.001 | 0.266 | 0.689 | Q3 | 58 | 98.3% | 2.5 | 6.7 | 57 | 99.5% | 2025-04-21 09:37:12 | 바로가기 |
페이지 이동: